It was reported that on (b)(6) 2023, a 25mm sjm masters series coated aortic valved graft was selected for use in a bentall procedure.During the procedure, the patient's activated clotting time (act) level was 100-110 seconds.A blood transfusion was required.It was noted during procedure that after the valved graft was implanted, there was blood leakage throughout the area, including the area where the artificial valve and artificial blood vessel of the valved graft were connected.The area was reinforced with a pericardial patch and hemostatic material.After the procedure, the patient's international normalized ratio (inr) was 1.8.The physician was not sure if the cause of the bleeding was due to a leak from the blood vessel or a gap between the blood vessel and the valve.The patient was reported as stable and was later discharged.
|
An event of blood leakage throughout the area, including the area where the artificial valve was reported.It was also reported that the area was reinforced with a pericardial patch and hemostatic material.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|